PALI (Palisade Bio) Net Margin %: 0.00% (As of Mar. 2026)


PALI Palisade Bio Inc PALI
35 GF Score
Price $1.90
! 2 Warning Signs
View Full Analysis

What is Palisade Bio Net Margin %?

Palisade Bio PALI +5.59% 35 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates PALI with a GF Score™ of 35/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Palisade Bio ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Palisade Bio's Net Income for the three months ended in Mar. 2026 was $-9.60 Mil. Palisade Bio's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Palisade Bio's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Palisade Bio's Net Margin % or its related term are showing as below:


PALI's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Palisade Bio  (NAS:PALI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Palisade Bio Net Margin % Related Terms

Palisade Bio Net Margin % Historical Data

* Premium members only.

The historical data trend for Palisade Bio's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Palisade Bio Net Margin % Chart

Palisade Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 -4,920.00 0.00 0.00

Palisade Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PALI vs PBYI, NWBO, PROK: Net Margin % Comparison

For the Biotechnology subindustry, Palisade Bio's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palisade Bio Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palisade Bio's Net Margin % distribution charts can be found below:

* The bar in red indicates where Palisade Bio's Net Margin % falls into.


PALI
35GF Score
Palisade Bio Inc PALI
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palisade Bio Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Palisade Bio's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-16.781/0
= %

Palisade Bio's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-9.6/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Palisade Bio (PALI) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Palisade Bio and its competitors. According to the industry distribution chart, Palisade Bio ranks #999999 out of 946 companies in the Biotechnology industry.
Is Palisade Bio's Net Margin % too high?
Palisade Bio's current Net Margin % is 0.00%. Based on the distribution chart, Palisade Bio ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Palisade Bio has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Palisade Bio's Net Margin % compare to PBYI and NWBO?
According to the Biotechnology industry distribution chart, Palisade Bio ranks #999999 out of 946 companies for Net Margin %. This places Palisade Bio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Palisade Bio and its competitors. Palisade Bio's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Palisade Bio stock overvalued right now?
Palisade Bio (PALI) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Palisade Bio's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Palisade Bio (PALI), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Palisade Bio Business Description

Address 4600 South Syracuse Street, Suite 900, Denver, CO, USA, 80237
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
35GF Score

Get the complete analysis for PALI

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.90
Price